Literature DB >> 16126720

Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein.

Luyun Huang1, Jungwook Hwang, Suresh D Sharma, Michele R S Hargittai, Yingfeng Chen, Jamie J Arnold, Kevin D Raney, Craig E Cameron.   

Abstract

Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) has been shown to antagonize numerous cellular pathways, including the antiviral interferon-alpha response. However, the capacity of this protein to interact with the viral polymerase suggests a more direct role for NS5A in genome replication. In this study, we employed two bacterially expressed, soluble derivatives of NS5A to probe for novel functions of this protein. We find that NS5A has the capacity to bind to the 3'-ends of HCV plus and minus strand RNAs. The high affinity binding site for NS5A in the 3'-end of plus strand RNA maps to the polypyrimidine tract, an element known to be essential for genome replication and infectivity. NS5A has a preference for single-stranded RNA containing stretches of uridine or guanosine. Values for the equilibrium dissociation constants for high affinity binding sites were in the 10 nM range. Two-dimensional gel electrophoresis followed by Western blotting revealed the presence of unphosphorylated NS5A in Huh-7 cells stably expressing the subgenomic replicon. Moreover, RNA immunoprecipitation and NS5A pull-down experiments showed the capacity of replicon-derived NS5A to bind to synthetic RNA and the HCV genome, respectively. Deletion of all of the casein kinase II phosphorylation sites in NS5A supported stable replication of a subgenomic replicon in Huh-7. However, this derivative could not be labeled with inorganic phosphate, suggesting that extensive phosphorylation of NS5A is not required for the replication functions of NS5A. The discovery that NS5A is an RNA-binding protein defines a new functional target for development of agents to treat HCV infection and a new structural class of RNA-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126720     DOI: 10.1074/jbc.M508175200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  122 in total

Review 1.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Structure-function relationships of the viral RNA-dependent RNA polymerase: fidelity, replication speed, and initiation mechanism determined by a residue in the ribose-binding pocket.

Authors:  Victoria S Korneeva; Craig E Cameron
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

Review 3.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

4.  Picornavirus genome replication: assembly and organization of the VPg uridylylation ribonucleoprotein (initiation) complex.

Authors:  Harsh B Pathak; Jamie J Arnold; Phillip N Wiegand; Michele R S Hargittai; Craig E Cameron
Journal:  J Biol Chem       Date:  2007-03-27       Impact factor: 5.157

5.  Single strand binding proteins increase the processivity of DNA unwinding by the hepatitis C virus helicase.

Authors:  Vaishnavi Rajagopal; Smita S Patel
Journal:  J Mol Biol       Date:  2007-11-01       Impact factor: 5.469

6.  Viral manipulation of host mRNA decay.

Authors:  Liang Guo; Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Future Virol       Date:  2018-02-23       Impact factor: 1.831

7.  Endocytic Rab proteins are required for hepatitis C virus replication complex formation.

Authors:  David Manna; Jason Aligo; Chenjia Xu; Wei Sun Park; Hasan Koc; Won Do Heo; Kouacou V Konan
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

8.  Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B.

Authors:  Qingxia Han; David Manna; Kerry Belton; Richard Cole; Kouacou V Konan
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.

Authors:  Guofeng Cheng; Ana Montero; Pablo Gastaminza; Christina Whitten-Bauer; Stefan F Wieland; Masanori Isogawa; Brenda Fredericksen; Suganya Selvarajah; Philippe A Gallay; M Reza Ghadiri; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

10.  The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner.

Authors:  Elizabeth M Quezada; Caroline M Kane
Journal:  Open Biochem J       Date:  2009-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.